Fulcrum Therapeutics, Inc. (NASDAQ: FULC) has seen a 136% increase in the last quarter, but long-term investors have suffered a 60% loss.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) has seen a 136% increase in the last quarter, but long-term investors have suffered a 60% loss.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing